DOI: 10.1128/JCM.01228-20
ABSTRACT
Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) got off to a slow start in the United States. In this commentary, I describe my experience with CoV disease 2019 (COVID-19), with a focus on being tested at the University of North Carolina—Chapel Hill Respiratory Diagnostic Center on its inaugural day.
The views expressed in this article do not necessarily reflect the views of the journal or of ASM.
- Copyright © 2020 American Society for Microbiology.
